{"task_id": "6c5525bb0829eb14", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 112/464)", "text": "plus organ\ndysfunction)\nSepsis and Septic Shock\n99\n\n--- Page 121 ---\nPATHOPHYSIOLOGY (CONT\u2019D)\n\u0004\nSEPTIC\nSHOCK\nsepsis induced hypotension (i.e.\nSBP <90 mmHg) despite adequate fluid resuscita\ntion or vasopressor dependence.\nSIMPLIFIED MECHANISM OF INJURY\ninfection !\nsystemic inflammation (SIRS) ! complement activa\ntion, # fibrinolytics ! endothelial dysfunction, micro\nvascular coagulopathy and thrombosis ! organ fail\nure. Too little or too much host response\nMECHANISM OF ACUTE KIDNEY INJURY IN SEPSIS\n1. Hypotension,\nincreased\ncatecholamines\nand\nvasopressor resistance to norepinephrine and\nangiotensin II ! renal ischemia ! acute kidney\ninjury\n2. Hyperglycemia ! white cell dysfunction and\ninflammation ! acute kidney injury\n3. Disseminated microvascular coagulation ! glo\nmerular and vascular microthrombosis ! acute\nkidney injury\nBAND\nCELLS\nneutrophils\nwith\nunsegmented\nnuclei, a developmental stage immediately preced\ning the mature segmented form\n\u0004\nLEFT SHIFT\nband cell count >0.7\u0002109/L, com\nmonly seen in infections\n\u0004 \"SEVERE\" LEFT SHIFT\ncells as immature as meta\nmyelocytes may be seen in left shift in response to\ninfection, but unusual to see more immature cells\n(myelocytes, promyelocytes, blasts). When pre\nsent, suggestive of myeloproliferative disorder\n(chronic myelogenous leukemia, agnogenic mye\nloid metaplasia, or one of the various forms of\nacute leukemia)\nINVESTIGATIONS\nBASIC\n\u0004\nLABS\nCBCD, lytes, urea, Cr, glucose, AST, ALT,\nALP, bilirubin, albumin, troponin, CK, INR, PTT,\nlactate, urinalysis, random cortisol\n\u0004\nMICROBIOLOGY\nblood C&S, sputum Gram stain/\nAFB/C&S, urine C&S\n\u0004\nIMAGING\nCXR\n\u0004 ABG\nSPECIAL\n\u0004 ScvO2 MONITORING\nwith internal jugular or\nsubclavian central line insertion\n\u0004\nLUMBAR\nPUNCTURE\nif\naltered\nlevel\nof\nconsciousness\n\u0004\nTHORACENTESIS\nif significant pleural effusion(s)\n\u0004\nPARACENTESIS\nif ascites\nMANAGEMENT\nACUTE\nABC, O2, IV, consider intubation/mechani\ncal ventilation\nMANAGEMENT (CONT\u2019D)\nRESUSCITATION (early goal directed therapy)\nfluids (Ringer\u2019s lactate or NS 3 10 l IV, consider col\nloids such as PRBC, albumin, hydroxyethyl starches)\nand\nvasopressors/inotropes\n(norepinephrine\n1 30 mcg/min IV, vasopressin 0.01 0.04 U/min IV,\ndobutamine 2.5 15 mg/kg/min IV) during first 6 h to\nmaintain CVP 8 12 mmHg, MAP \u000765 mmHg or SBP\n>90 mmHg, urine output \u00070.5 mL/kg/h and central\nvenous or mixed venous saturation \u000770%\nNEJM 2001 345:19\nANTIMICROBIALS\nearly empiric antimicrobials,\nshould be administered ASAP, order STAT. If sus\npect pulmonary source, macrolide plus b lactam for\ncommunity acquired pneumonia, anti pseudomonal\nplus aminoglycoside or fluoroquinolone \t vancomy\ncin (if high level MRSA endemicity) for nosocomial\npneumonia. If suspect urinary source, third genera\ntion cephalosporin, fluoroquinolone, or aminoglyco\nside. If suspect intra abdominal source, b lactam/b\nlactamase inhibitor or carbapenem. Tailor antimi\ncrobials once organism(s) identified. Know your\nlocal epidemiology\nSOURCE CONTROL\nabsolutely imperative. Must\ndrain abscesses and debride devitalized tissues to\nachieve source control\nGLYCEMIC CONTROL\ninsulin infusion to keep\nserum glucose <10 mmol/L [<180 mg/dL], maintain\ning euglycemia may improve outcomes; however,\nmust avoid hypoglycemia\nACTIVATED PROTEIN C\nfor patients at high risk of\ndeath (APACHE score \u000725, sepsis induced multiple\norgan failure, septic shock, or sepsis induced ARDS,\nwith no absolute contraindications related to bleed\ning risk, or relative contraindications that outweigh\npotential benefit). Decreased mortality from 30.8% to\n24.7%, but increased bleeding rate from 2% to 3.5%\nNEJM 2002 347:13\nSTEROIDS\ncontroversial as no reduction in mortal\nity but hasten time to shock reversal, administer\nhydrocortisone 50 mg IV q6h in patients with vaso\npressor dependent shock\nBLOOD PRODUCTS\nin septic shock patients with\nlow ScvO2 during the first 6 h of resuscitation, the\ntarget hematocrit should be 30%. In stable patients,\nthe threshold for transfusion should be hemoglobin\n<70 g/L, with a target of 70 90 g/L\nPROPHYLAXIS\nDVT (unfractionated heparin SC,\nLMWH, fondaparinux, pneumatic stockings), stress\nulcer (ranitidine 50 mg IV q8h or 150 mg PO/NG q12h)\nSPECIFICS\nARDS\n(lung protective\nventilation),\nacute kidney injury (avoid nephrotoxins, supportive\nrenal replacement therapy), early enteral feeding\n100\nSepsis and Septic Shock", "text_length": 4318, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 112/464)", "type": "chunk", "chunk_index": 111, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.398115", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.398843", "status": "complete", "chunks_added": 3}